BANZEL (rufinamide) oral suspension

BANZEL is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults. Brand Name: BANZEL (rufinamide) oral suspension Initial U.S. Approval: 2008

Home | Rufinamide oral suspension

BANZEL (rufinamide) oral suspension price in India and Overseas
BANZEL (rufinamide) Oral Suspension

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

BANZEL (rufinamide) Oral Suspension

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders

BANZEL is an add-on treatment proven to significantly reduce the severity and frequency of a broad range of seizures in adults and children with Lennox-Gastaut syndrome (LGS).

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Rufinamide was approved by the US Food and Drug Administration (FDA) in November 2008, as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children four years and older and adults.

Drug (Brand / Generic): BANZEL / rufinamide
Current Indications: treat Lennox–Gastaut syndrome and various other seizure disorders
Marketed by:: Eisai, Inc
Approval Date: 2008

Dosage forms and strengths of BANZEL (rufinamide).
Film-coated tablets: 200 mg (pink), 400 mg (pink)
Oral suspension: 40 mg/mL

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.